A Phase II Study of R115777 (Zarnestra) (NSC # 702818, IND# 58,359) in Children With Recurrent or Progressive: High Grade Glioma, Medulloblastoma/PNET or Brainstem Glioma
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2013
At a glance
- Drugs Tipifarnib (Primary)
- Indications Brain cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2007 Status changed from in progress to completed.
- 06 Sep 2005 New trial record.